Home
>
National Drug Code (NDC)
>
Norethindrone Acetate
Norethindrone Acetate - 42291-650-90 - (Norethindrone)
Drug Information of Norethindrone Acetate
| Product NDC: | 42291-650 |
| Proprietary Name: | Norethindrone Acetate |
| Non Proprietary Name: | Norethindrone |
| Active Ingredient(s): | 5 mg/1 & nbsp; Norethindrone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Norethindrone Acetate
| Product NDC: | 42291-650 |
| Labeler Name: | AvKARE, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200275 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130618 |
Package Information of Norethindrone Acetate
| Package NDC: | 42291-650-90 |
| Package Description: | 90 TABLET in 1 BOTTLE (42291-650-90) |
NDC Information of Norethindrone Acetate
| NDC Code | 42291-650-90 |
| Proprietary Name | Norethindrone Acetate |
| Package Description | 90 TABLET in 1 BOTTLE (42291-650-90) |
| Product NDC | 42291-650 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Norethindrone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130618 |
| Marketing Category Name | ANDA |
| Labeler Name | AvKARE, Inc. |
| Substance Name | NORETHINDRONE ACETATE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |
